ArticleJournal of neuro-oncology2025

Do the benefits of IDH mutations in high-grade glioma persist beyond the first recurrence? A multi-institutional retrospective analysis.

Anne R Lally et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.